1 week ago
Dr. Marc Bjurlin Recognized as 2026 Castle Connolly Top Doctor
We are pleased to share that Dr. Marc Bjurlin has been named to the 2026 Castle Connolly Top Doctors list for the first time.
Tag: Bjurlin
3 weeks ago
UNC Urology Receives Prestigious Designation as a National “Single-Port Robotic Surgery Observation Site”
The Department of Urology at the UNC School of Medicine has been designated an official Single-Port (SP) Robotic Surgery Case Observation Site, placing UNC among fewer than 20 programs nationwide to receive this distinction from Intuitive.
3 months ago
NC TraCS Program Alumni Are Researching The Patient Side Of Clinical Trials
UNC physician Marc Bjurlin teamed up with his colleagues from the Clinical Trialist Training Program on a unique series of studies aimed at improving and expanding clinical trials.
1 year ago
Dr. Marc Bjurlin Spotlights Connection Between Smoking and Bladder Cancer on BCAN Podcast
In a recent episode of the Bladder Cancer Matters podcast titled “Unpacking Smoking and Bladder Cancer,” Dr. Marc Bjurlin shared critical insights into the connection between smoking and bladder cancer.
1 year ago
Dr. Marc Bjurlin Appointed Vice Chair of Research for UNC Urology
UNC Urology is proud to announce that Marc Bjurlin, DO, MSc, FACOS, has been appointed the department's Vice Chair of Research, a role that will further elevate our research mission and commitment to advancing urologic care.
1 year ago
State-of-the-Art Robotic Surgery Techniques Minimize Urinary Complications For Men Undergoing Prostatectomy (Removal of Prostate)
Robotic Assisted Laparoscopic Prostatectomy (RALP) is a minimally invasive surgery for men with prostate cancer. The procedure involves making a series of small holes in the abdomen through which robotic arms controlled by the surgeon are used to remove the prostate with a high degree of accuracy and precision. RALP is now the most common type of prostatectomy performed in the U.S.
1 year ago
Bjurlin Shares Expertise with the Oncological Urology Section of the Polish Urological Society in Warsaw, Poland
UNC Urology is proud to recognize Dr. Marc Bjurlin for his contributions as an invited speaker at the 11th Symposium of the Oncological Urology Section of the Polish Urological Society held in Warsaw, Poland.
2 years ago
Bjurlin, Nielsen and Schultz Receive 2024 “Award for Carolina Care Excellence”
Congratulations to Heather Schultz, NP, FAUNA, Marc Bjurlin, DO, MSc, FACOS, and Dr. Matthew Nielsen, MD, MS, FACS for receiving the UNC Health 2024 "Award for Carolina Excellence”
2 years ago
UNC Urology Participates in Cutting Edge Clinical Trial of Potential New “Combination Therapy” for Bladder Cancer
A multi-center Phase 3 clinical trial named “QUILT” is exploring a potential new treatment that involves administering BCG (Bacillus Calmette-Guerin) combined with an experimental drug known as N-803 (Nogapendekin alfa inbakicept), with the goal of providing a synergistic therapeutic effect to some Bladder Cancer patients.
2 years ago
UNC Urology’s Dr. Marc Bjurlin Spotlights Prostate Cancer on ABC11 Eyewitness News
UNC Urology Associate Professor and Director of Clinical Trials, Dr. Marc Bjurlin, spoke on a recent ABC11 Eyewitness News segment addressing Prostate Cancer Awareness. The segment, led by Bianca Holman, sheds light on the heightened risk for prostate cancer faced by black men.
2 years ago
Dr. Marc Bjurlin Takes the Stage in Florence, Italy at the 8th Annual European Conference on Tobacco Control
Dr. Bjurlin was honored with an invitation to lead a plenary lecture focusing on the intricate relationship between smoking and bladder cancer at the 8th Annual European Conference on Tobacco Control (ECTC) hosted in Florence, Italy
3 years ago
UNC Urologists Perform Innovative “Transperineal Biopsies” to Reduce Risks and Optimize Prostate Cancer Detection
Urologists at UNC are at the forefront of performing a highly effective procedure called “transperineal biopsies” of the prostate, in which the biopsy needle enters through the patient’s perineum instead of the rectum. At UNC, traditional transrectal biopsies have a very low risk of serious infection.